Big Gain For Aytu BioPharma, Inc.
Aytu BioPharma, Inc. (AYTU:NASDAQ) jumped higher at $2.59, a gain of 91.9%. On Thu, May 15, 2025, AYTU:NASDAQ touched a New 2-Week High of $2.59. The stock appeared on our News Catalysts scanner on Thu, May 15, 2025 at 04:08 AM in the 'MISCELLANEOUS' category. From Thu, May 01, 2025, the stock recorded 40.00% Up Days and 27.27% Green Days
About Aytu BioPharma, Inc. (AYTU:NASDAQ)
Aytu BioScience Inc is a specialty pharmaceutical company commercializing novel products addressing patient needs. The company markets a portfolio of prescription products addressing large therapeutic markets. The primary care portfolio includes Natesto, the only FDA-approved nasal formulation of testosterone, ZolpiMist, the only FDA-approved oral spray prescription sleep aid, and Tuzistra XR, the only FDA-approved 12-hour codeine-based antitussive syrup. The pediatric portfolio includes AcipHex Sprinkle, Cefaclor, Karbinal ER, and Poly-Vi-Flor and Tri-Vi-Flor.
Top 10 Gainers:
- Click Holdings Limited (CLIK:NASDAQ), 153.5%
- Aytu BioPharma, Inc. (AYTU:NASDAQ), 91.85%
- Hempacco Co., Inc. (HPCO:NASDAQ), 87.5%
- Foot Locker, Inc. (FL:NYSE), 85.7%
- Kindly MD, Inc. (KDLY:NASDAQ), 81.18%
- NuCana plc (NCNA:NASDAQ), 54.34%
- Graphjet Technology (GTI:NASDAQ), 51.55%
- Asset Entities Inc. (ASST:NASDAQ), 46.17%
- Gryphon Digital Mining, Inc. (GRYP:NASDAQ), 42.46%
- Cabaletta Bio, Inc. (CABA:NASDAQ), 39.23%